RUO‘ZENLog in
Market movers › Nov 12, 2026

Why stocks rose and fell on Nov 12, 2026

44 stocks with notable moves: companies over $10B that moved more than 5%, plus the sharpest moves among smaller companies. For each — the day's headlines with a link to the source; if there was no news, the page says so. The strongest sector was Energy (+0.87%), the weakest Basic Materials (−2.28%).

Gainers · 5

FRMI+13.8%Fermiearnings
  • Market pulseFermi reports fiscal Q3 net loss of $141.6 million on zero revenue and says TensorWave lease and related AMD credit support agreement were terminated
  • ACCESSWIREFermi Announces New Agreements with Investment-Grade Hyperscaler and Third Quarter 2026 Financial Results
  • BenzingaFermi Q3 EPS $(0.22) Misses $(0.09) Estimate

The trigger was the quarterly report: EPS +74% year over year, 463.1% below the estimate.

HUBS+6.4%HubSpot
AMD+5.9%AMD
AVGO+5.5%Broadcom
ANET+5.1%Arista Networks

Decliners · 39

BZ−25.3%Kanzhun
  • Market pulseNo clear catalyst identified; Kanzhun plunge far exceeds Hong Kong technology weakness
  • Market pulseNo clear catalyst identified; Kanzhun extends premarket selloff amid broader China ADR weakness
CTVA−24.3%Cortevaearnings
  • Market pulseCorteva reports Q3 adjusted EBITDA down 17% year over year and updates 2026 guidance to $1.1 billion–$1.125 billion in EBITDA and $0.76–$0.80 adjusted EPS
  • Market pulseCorteva reports fiscal Q3 2026 revenue of $1.6B, down 39% YoY, and non-GAAP EPS of $0.06, beating EPS but missing revenue estimates
  • PR NewswireCorteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

The trigger was the quarterly report: EPS +274% year over year, 231.9% above the estimate.

NBIS−16.8%Nebiusearnings

The trigger was the quarterly report: EPS +162% year over year, 140.6% above the estimate.

CLBT−14.3%Cellebrite DIearnings
  • Market pulseCellebrite beats Q3 estimates and guidance with non-GAAP EPS $0.10 (+25% YoY), revenue $149.0M (+18% YoY), and raises EBITDA outlook
  • Market pulseCellebrite cuts 2026 revenue outlook to $553 million–$558 million while raising adjusted EBITDA guidance
  • PR NewswireCellebrite Reports Third-Quarter 2026 Results

The trigger was the quarterly report: EPS +25% year over year, 6.3% above the estimate.

MANE−13.6%Veradermics
  • Market pulseNo clear catalyst identified; biotech weakness accompanies MANE's reversal after four-session record run
  • Market pulseLongitude’s $37.6M Rule 144 sale filing knocks Veradermics 10% lower during Thursday trading
BTDR−12.8%Bitdeer Technologies

No news on Bitdeer Technologies today. The Technology sector moved −0.95% (median).

DGII−12.7%Digi Internationalearnings

The trigger was the quarterly report: EPS +39% year over year, 2.1% above the estimate.

NVAX−12.2%Novavax
GPN−12.0%Global Payments
GDS−11.4%GDS
  • Market pulseNvidia CEO resignation and reported U.S. chip-access curbs drive GDS 13% lower
LCID−11.3%Lucid
SMCI−11.3%Super Micro
LIFE−10.9%Ethos Technologies

No news on Ethos Technologies today. The Financial sector moved −0.93% (median).

ACHR−10.9%Archer Aviation
AZTA−10.3%Azenta
  • Market pulseAzenta beats FY revenue, guides to faster 2027 growth and margin expansion
  • Market pulseEarnings beat and above-consensus FY27 guidance lift Azenta 21% in Wednesday trading
  • Fiscal.AiNeedham Increases Price Target on Azenta to $57
HWC−10.2%Hancock Whitney
  • Market pulseTrustmark acquisition announcement knocks Hancock Whitney shares 5.5% lower before Thursday's market open
  • Business WireHancock Whitney Corporation to Acquire Trustmark Corporation
  • BenzingaHancock Whitney (HWC) to acquire Trustmark (TRMK)
ETON−10.2%Eton Pharmaceuticals
TIGO−9.6%Millicom International Cellular
  • Market pulseMSCI Global Standard removal sends Millicom down 11% in early regular-session trading
SMMT−9.4%Summit Therapeutics
  • Market pulseNo clear catalyst identified; FDA-event de-risking and biotech weakness frame Summit's 9% decline
  • Market pulseNo clear catalyst identified; biotech selloff and imminent FDA decision frame SMMT’s 9% decline
IONQ−9.4%IonQ
KDP−7.4%Keurig Dr Pepper
QXO−7.2%QXO
BABA−7.1%Alibaba
MRNA−7.0%Moderna
  • Market pulseModerna targets annual cash costs of $4 billion–$4.5 billion from 2027 through 2030 and says amended Ares credit-facility terms cut interest rates by 75 basis points.
  • Fiscal.AiArgus Adjusts Price Target on Moderna to $280 From $180
  • ACCESSWIREModerna Outlines Next Phase of Growth at Analyst Day
NXT−6.9%Nextpower
CRWV−6.9%CoreWeave
MSTR−6.5%MicroStrategy
FIS−6.1%Fidelity National Information Services
STLA−6.1%Stellantis
ASTS−5.8%AST SpaceMobile
RDDT−5.8%Reddit
PCVX−5.7%Vaxcyte

No news on Vaxcyte today. The Healthcare sector moved −1.72% (median).

KYMR−5.7%Kymera Therapeutics

No news on Kymera Therapeutics today. The Healthcare sector moved −1.72% (median).

RIVN−5.5%Rivian
DAL−5.2%Delta Air Lines
MDLN−5.2%Medline

No news on Medline today. The Healthcare sector moved −1.72% (median).

DVA−5.1%DaVita
RKT−5.1%Rocket Companies
RGLD−5.0%Royal Gold

No news on Royal Gold today. The Basic Materials sector moved −2.28% (median).

← Nov 11, 2026

Headlines link to their sources. We do not copy article text.